PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI)

CUSIP: 74587V107

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / Common Stock
Shares outstanding
49,633,071
Total 13F shares
32,269,617
Share change
+2,193,934
Total reported value
$2,529,775,949
Put/Call ratio
45%
Price per share
$78.40
Number of holders
131
Value change
+$177,573,758
Number of buys
54
Number of sells
105

Quarterly Holders Quick Answers

What is CUSIP 74587V107?
CUSIP 74587V107 identifies PBYI - PUMA BIOTECHNOLOGY, INC. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) as of Q4 2015

As of 31 Dec 2015, PUMA BIOTECHNOLOGY, INC. - Common Stock (PBYI) was held by 131 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,269,617 shares. The largest 10 holders included ADAGE CAPITAL PARTNERS GP LLC, FMR LLC, Grantham, Mayo, Van Otterloo & Co. LLC, ORBIMED ADVISORS LLC, Capital Research Global Investors, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, MILLENNIUM MANAGEMENT LLC, Point72 Asset Management, L.P., and STATE STREET CORP. This page lists 131 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.